Report
What do drug monopolies cost consumers in developing countries?
Abstract: This paper quantifies the effects of drug monopolies and low per-capita income on pharmaceutical prices in developing economies using the example of the antiretroviral drugs (ARVs) used to treat HIV.
Keywords: intellectual property rights; international price discrimination; TRIPS agreement; pharmaceutical industry; markups;
JEL Classification: D4; F13; L1; L65; O34;
Access Documents
File(s): File format is text/html https://www.newyorkfed.org/medialibrary/media/research/staff_reports/sr530.html
File(s): File format is application/pdf https://www.newyorkfed.org/medialibrary/media/research/staff_reports/sr530.pdf
Authors
Bibliographic Information
Provider: Federal Reserve Bank of New York
Part of Series: Staff Reports
Publication Date: 2011-12-01
Number: 530
Note: For a published version of this report, see Rebecca Hellerstein, "What Do Drug Monopolies Cost Consumers in Developing Countries?" Economics Letters 116, no. 1 (July 2012): 108-111.